Portolan Capital Management’s Qiagen QGEN Stock Holding History

Portolan Capital Management’s Portfolio QGEN Stock Details QGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-90,182	Closed	-$4.06M	–	167
2025 Q4	$4.06M	Buy	+90,182	New	+$4.17M	0.22%	114

Other funds holding QGEN

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Amundi Paris, France $416B AUM 44.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Portolan Capital Management's QGEN Position: Q1 2026 in Review

Portolan Capital Management sold out of Qiagen (QGEN) in Q1 2026, closing a stake of 90,182 shares — an estimated $4.06M sold.

Portolan Capital Management first reported a position in QGEN in Q4 2025 and held it in 1 quarter. The position peaked at $4.06M in Q4 2025. 346 funds tracked by Wall St. Rank hold QGEN as of Q1 2026.

Portolan Capital Management reported no remaining Qiagen position as of Q1 2026 after selling out during the quarter.
Portolan Capital Management sold 90,182 Qiagen shares in Q1 2026, an estimated $4.06M.
Portolan Capital Management first reported a position in Qiagen in Q4 2025 and held it in 1 quarter.
Portolan Capital Management's Qiagen position peaked at $4.06M in Q4 2025.
346 funds tracked by Wall St. Rank held Qiagen as of Q1 2026.

Based on Portolan Capital Management's 13F filing for Q1 2026, filed 15 May 2026.